RBC Capital Upgrades PTC Therapeutics (PTCT) to Outperform, 'NVS HD Deal Meaningfully Improves Fundamentals'
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams upgraded PTC Therapeutics (NASDAQ: PTCT) from Sector Perform to Outperform with a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
